Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Vasvi Singh Added: 7 months ago
Navigate the diagnostic complexities of cardiac amyloidosis through expert multimodality imaging techniques with Dr Vasvi Singh.This comprehensive presentation, part of the Cardiomyopathies track, addresses the critical role of advanced imaging in diagnosing cardiac amyloidosis. Dr Singh explores the nuanced differences between SPECT and SPECT-CT imaging capabilities, providing practical insights… View more
Author(s): Ahmad Masri Added: 6 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34… View more
Author(s): Julian Gillmore , Margot K Davis Added: 7 months ago
This programme, featuring Prof Julian Gillmore (University College London, London, UK) and Dr Margot Davis (Vancouver General Hospital, Vancouver, CA) offers an in-depth exploration of ATTR amyloidosis, highlighting the value of observational research in understanding disease presentation, treatment patterns, and outcomes. Viewers will learn about the pathophysiology and spectrum of the condition… View more
Added: 1 year ago
In this illuminating episode of Parallax, Dr Ankur Kalra engages with Dr Jonathan Drezner, Director of Sports Cardiology at the University of Washington, who explores the complex world of cardiovascular risk in competitive athletes.Dr Drezner traces the evolution of sports cardiology from watershed moments involving high-profile athletes like Hank Gathers and Reggie Lewis to today's sophisticated… View more
Author(s): Navdeep Tangri , James Burton , David Wheeler Added: 1 year ago
Part one of this two-part programme focuses on our current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK), Dr Navdeep Tangri (University of… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights… View more